Extensive apoptosis in ductal carcinoma in situ of the breast
โ Scribed by Stephan Bodis; Kalliopi P. Siziopikou; Stuart J. Schnitt; Jay R. Harris; David E. Fisher
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 537 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
More than 50% of breast ductal carcinomas in situ (dcis) contain significant histologic necrosis, an important prognostic factor for determining recurrence and progression to invasive breast cancer. we have examined whether the mechanism of this spontaneous cell death might be apoptosis, a genetically encoded suicide pathway that may be triggered by various events including dysregulated cell proliferation.
Methods:
Twenty-five untreated dcis cases accessioned at our institution were examined for subtype, grade, and presence of apoptosis using two criteria: (1) cellular morphology (shrinkage, nuclear condensation, fragmentation, apoptotic bodies, and lack of inflammatory component); and (2) terminal transferase (tunel) staining of dna fragmentation, a characteristic though less specific feature of apoptosis. immunohistochemical staining was also carried out to assess whether wild-type p53, a regulator of apoptosis, was associated with this cell death.
Results:
In all 19 cases with intraductal necrosis, cellular morphology was consistent with apoptotic death, despite its presence within sheets of "geographic necrosis." additionally, the identical regions were all strongly tunel-positive. no evidence of tunel staining was seen in 5 grade i dcis cases without intraductal necrosis. immunohistochemical staining suggested that this apoptosis was independent of p53 mutational status.
Conclusions:
Extensive intraductal necrosis in dcis is likely to represent apoptosis. however, it is unlikely that this apoptosis is regulated by p53. the apparently abundant apoptosis identified here, particularly in high grade dcis, may be important in explaining why spontaneous cell death in dcis is associated with a worse prognosis.
๐ SIMILAR VOLUMES
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents
Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering
## BACKGROUND. There is controversy and confusion regarding therapy for patients with ductal carcinoma in situ (DCIS) of the breast. The Van Nuys Prognostic Index (VNPI) was developed to aid in the complex treatment selection process.